measuregroup/AID1880119

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482052740_AID1880119_PMID35436119_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID242459086_AID1880119_PMID35436119_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482070094_AID1880119_PMID35436119_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482053605_AID1880119_PMID35436119_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482053090_AID1880119_PMID35436119_VALUE3
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33261
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Inhibition of CYP2C19 (unknown origin) assessed as remaining activity at 10 uM relative to control
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482053090 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482053605 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482052740 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242459086 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482070094
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1880119

Total number of triples: 15.